The announcement this summer that researchers had detected brain waves in "mini-brains" they'd grown in the lab has raised a whole new set of important ethical questions around this kind of fundamental research.
Brain organoids have emerged in recent years as a powerful new biomedical tool to study human brain developmentand disorders of the brain like Alzheimer's and multiple sclerosis.
But as researchers develop techniques to grow these nodules of brain tissue ever larger andwith more neurological complexity, the workis raising profound ethical questions about whether they might one day be able to think and feel pain.
"If we really are capable of producing something similar to the human brain, then this will open a can of ethical worms that will distinguish [brain organoid] research from other areas of biomedical inquiry," Canadian bioethicist Kalina Kamenova told Quirks & Quarks host Bob McDonald.
For the last decade, researchers have been using stem cells to grow clusters of neurons and glial cells the critical cell types that make up the brain in bio-reactors that provide carefully tailored conditions for growth. As the cells multiply, they're able to self-organize to resemble a fragment brain tissue similar to a piece of a developing brain.
"Brain organoids provide us an opportunity to study how the human brain develops and functions, and provide us key insights into neurological disorders that we simply could not study before," said Paul Tesar, from the Department of Genetics and Genome Sciences at Case Western Reserve University School of Medicine in Cleveland, Ohio.
Tesar has been using human brain organoidsto test new treatments for multiple sclerosis. MS is characterized by the loss of myelin an insulating sheath around nerve cells. In previous work,Tesar and his colleagues had developed a drug that proved effective in stimulating brain tissue to regenerate myelin which they had tested in mice.
Using human brain organoids, the team was able to show the drug was also effective in human brain tissue, and they're now moving towardsclinical trials in MS patients.
Work on brain organoids took a new turn when prominent neuroscientist Alysson Muotrifrom the University of California at San Diego, published a paper in August that reported on the detection of brain waves in brain organoidsfor the first time.
Muotri is a scientist known for pushing boundaries in research, having previously studied the effects of space travel on brain organoids and developed brain organoids from stem cells modified with Neanderthal genes.
Prior to the publication of Muotri's most recent work, many organoid researcher had been skeptical that brain organoidswould ever generate brain waves. Outside of a body, many thought the conditions weren't right for brain organoids to mature and form the neural circuits necessary for coordinated electrical activity.
Muotri's lab was able to optimize their growth formula so they could grow organoids that could live for several years.
Initially,they observed no coordinated activity, just occasional random firing of neurons.However, as the brain organoids started to mature, they began to observe increasing synchronization of activity as the neurons formed synapses over time. Eventually, this developed into waves of neural electrical activity that were similar to brainwaves observed inpreterm infants.
Muotri thinks his experiments have demonstrated that brain organoids are capable of forming the sophisticated networks that are associated with human behaviour and cognition.
"What we see in the brain organoid is the beginning of something that will lead to these sophisticated networks," said Muotri. "That's why this is so important."
Muotriis so convinced of the value of brain organoids in studying human brain disorders that he wants to continue to push the field forward, and facethe ethical hurdles as they come.
Even the most advanced organoid models today are far from a fully functioning brain. They don't represent all the cell types in the brain, let alone the differentiation of different brain regions.
But Muotri is pushing for that development, and thinks it's entirely possible to do so. His lab has already grown organoids similar to cortical tissue and is working on a mini-thalamus. He's looking towards interconnecting these, perhaps providing sensory information to the brain organoids to help them 'see.'
"As we do that, what we expect to happen is the maturation of these organoids to increase and to become closer to the adult brain."
Could this mean brain organoids could one day feel other sensations, like pain or even at some point become self-aware. Muotri admits it's possible.
"We're getting closer and closer to a more grey zone," he admits. But he thinks the protocols we've already established for working humanely with animals and human subjects can help us understand the limits.
"That's when we team up with the ethicists to really decide how to use this material, and how to treat these brain organoids."
Canadian bioethicist Kalina Kamenova advises caution to be taken with the fieldgoing forward, and advocates for ethical oversight to monitor the research and to establish boundaries.
"[At some point], we'll need to establish whether we're dealing with human beings here and what moral standingit has, and what kind of legal protection should be afforded to it."
Muotri agrees that the field will need to be regulated in the future so as to ensure we treat brain organoids ethically perhaps mandating how to discard them after use and how many organoids to grow for each experiment. But he cautions against putting the brakes on the research too soon.
"I think the first thing we need to do is to see if we can actually get to that stage where these organoids are self-aware or if they feel pain," said Muotri. "I think,right now, it's premature and might actually damage the research. If we do actually get to that level, then I think it's time to pause and think about the consequences, and discuss with everybody in the field how far is too far and where is the limit."
See the original post here:
We're making tiny brains in the lab should we be worried for them? - CBC.ca
- BioRestorative Therapies Announces Notice of Allowance for a New Patent Application Related to its Off-the-Shelf ThermoStem Program -... - April 4th, 2021
- Transplant After CD19 CAR T-Cell Therapy Shows Durable Disease Control in Children, Young Adults With B-ALL - Cancer Network - April 4th, 2021
- Stem Cell Assay Market Changing Dynamics Of Competition With Forecast To 2030 The Bisouv Network - The Bisouv Network - April 4th, 2021
- Stem Cell Therapy Market Research Reveals Enhanced Growth During The Forecast Period 2017 2025 FLA News - FLA News - March 8th, 2021
- Adult Stem Cells Market Size, Share, Global Industry Overview, Challenges, Business Overview and Forecast Research Study 2024 (Effect of the COVID-19... - February 17th, 2021
- Be The Match encourages people of color to join bone marrow registry - KING5.com - February 17th, 2021
- Discovery for turning on cell repair in tissues and organs - Monash University - February 17th, 2021
- Manageable Safety Profile Observed in Phase 1 Studies Examining UCART19 for Pediatric and Adult Patients with B-Cell ALL - Cancer Network - February 11th, 2021
- The Very First Signs of an Immune Response Have Been Filmed in a Developing Embryo - ScienceAlert - February 11th, 2021
- JSP191 With Low Dose Irradiation and Fludarabine is Safe and Effective for Patients with MRD+ AML/MDS - Cancer Network - February 9th, 2021
- Creative Bioarray Offers Stem Cell Lines Generation Service for Promoting Scientific Research - Press Release - Digital Journal - February 9th, 2021
- JSP191 With Low Dose Irradiation and Chemotherpy Demonstrates Efficacy and Safety in MRD+ AML/MDS - Targeted Oncology - February 9th, 2021
- Stem Cells Market Value to Reach Around USD 17.79 Bn by 2027 - GlobeNewswire - February 4th, 2021
- Global Adult Stem Cells Market Revenue To Witness Humongous Elevation By 2026 Market Research Store Jumbo News - Jumbo News - February 4th, 2021
- Stem Cell Therapy Market to Score Past US$ 40.3 Billion Valuation by 2027: At a CAGR of 21.1% KSU | The Sentinel Newspaper - KSU | The Sentinel... - February 2nd, 2021
- Reduced Adult Neurogenesis Linked with Alzheimers Disease - The Scientist - February 2nd, 2021
- Regenerative Medicine (Bone and Joint) Market to Score Past US$ 14990.0 Million Valuation by 2027: CMI KSU | The Sentinel Newspaper - KSU | The... - February 2nd, 2021
- Orthopedic Regenerative Medicine Market Size to Witness A Lucrative Growth Over 2020-2027 | Curasan, Inc., Carmell Therapeutics Corporation, Anika... - February 2nd, 2021
- Adult Stem Cells Market Demand, Growth Challenges, Industry Analysis And Forecasts To 2026 | Epistem Ltd.,Globalstem,Mesoblast Ltd.,Brainstorm Cell... - February 2nd, 2021
- ToolGen ties up with 3D bioprinting company to apply induced pluripotent stem cells to gene correction - Aju Business Daily - February 2nd, 2021
- Medicine by Design researchers focus on promoting self-repair of the brain - News@UofT - January 31st, 2021
- Should You Buy Brainstorm Cell Therapeutics Inc (BCLI) Stock on Tuesday? - InvestorsObserver - January 31st, 2021
- Eye stem cell transplant to treat blindness bolsters retinal function in monkeys - FierceBiotech - January 14th, 2021
- Induction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidine - Science Advances - January 14th, 2021
- RoosterBio Partners with Sartorius to Advance Cell and Gene Therapy Manufacturing - GlobeNewswire - January 14th, 2021
- Reversing The Aging Clock With Epigenetic Reprogramming - Bio-IT World - January 14th, 2021
- New Models in Organoids Market Open New Vistas in Stem Cell Research for Cancer, Global Valuation to Reach US$ 12.8 Bn by 2030: TMR - PRNewswire - January 12th, 2021
- Health Canada Approves ONUREG (azacitidine tablets), First Maintenance Therapy for Patients in Remission from Acute Myeloid Leukemia - Canada NewsWire - January 12th, 2021
- Stem Cells Market 2020 Research Study including Growth Factors, Types and Application to 2026| Covid-19 Impact - Farming Sector - January 9th, 2021
- The real reason behind goosebumps - Jill Lopez - January 3rd, 2021
- Synthetic lethality across normal tissues is strongly associated with cancer risk, onset, and tumor suppressor specificity - Science Advances - January 3rd, 2021
- New Approaches to the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma - Targeted Oncology - January 3rd, 2021
- CAR T-Cell Therapies Are Set to Expand Into More Hematologic Malignancy Indications - Targeted Oncology - December 26th, 2020
- ElevateBio's HighPassBio Presents on Novel T Cell Receptor Cell Therapy for Leukemia Relapse at 62nd Annual ASH Meeting - Business Wire - December 6th, 2020
- CRISPR and another genetic strategy fix cell defects in two common blood disorders - Science Magazine - December 6th, 2020
- Multiple sclerosis iPS-derived oligodendroglia conserve their properties to functionally interact with axons and glia in vivo - Science Advances - December 6th, 2020
- UCART22 Safe and Active in CD22-Expressing B-Cell ALLs - Targeted Oncology - December 6th, 2020
- Cell Therapy Market Size, Share, Market Research and Industry Forecast Report, 2020-2027 (Includes Business Impact of COVID-19) - Cheshire Media - December 6th, 2020
- Stem Cells Market is Expected to Thrive at Impressive CAGR by 2025 - The Haitian-Caribbean News Network - December 5th, 2020
- Stem Cell Assay to Register Substantial Expansion by 2026| Merck, Thermo Fisher Scientific, GE Healthcare - The Haitian-Caribbean News Network - December 5th, 2020
- Stem Cell Therapy Global Market Report 2020-30: Covid 19 Growth and Change - GlobeNewswire - November 25th, 2020
- Functionally distinct resident macrophage subsets differentially shape responses to infection in the bladder - Science Advances - November 25th, 2020
- BioRestorative Therapies Emerges from Chapter 11 Reorganization Other OTC:BRTX - GlobeNewswire - November 20th, 2020
- Jakafi and Dacogen May Improve Overall Survival in Patients with MPN - Curetoday.com - November 20th, 2020
- BRTX-100; the Story of BioRestorative Therapies Inc (OTCMKTS: BRTX) - MicroCap Daily - November 20th, 2020
- As California Passes Prop 14, What Is Stem Cell Research and Why Is It Controversial? - Newsweek - November 16th, 2020
- Organoids mimic the early development of the heart in mouse embryos - BioNews - November 16th, 2020
- Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection - DocWire News - November 16th, 2020
- Cynata Therapeutics (ASX:CYP) begins phase three osteoarthritis trial - The Market Herald - November 16th, 2020
- $ 30.1 billion Worth Cell Expansion Market, Led by Thermo Fisher Scientific Inc, Becton, Dickinson and Company, Terumo BCT and Others. re:Jerusalem -... - November 3rd, 2020
- Impact of COVID-19 on Advanced Wound Care Management Market : Implications on Business Strategies, Countermeasures, Economic Impact - The Think... - November 1st, 2020
- Stem Cells Market 2020 Is Growing with Highest Size, Share of Top Key Players in the Industry and Forecast Survey Till 2024 - Zenit News - October 30th, 2020
- Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease - DocWire News - October 30th, 2020
- JadiCell Stem Cells Licensed by Therapeutic Solutions International for Brain Injury Significantly Increased Survival of COVID-19 Patients in Double... - October 29th, 2020
- Impact Of Covid 19 On Adult Stem Cells Market 2020 Industry Challenges, Business Overview And Forecast Research Study 2026 - PRnews Leader - October 29th, 2020
- APstem Therapeutics Announces Successful FDA INTERACT Meeting Regarding AP-Skin-01, an Off-the-Shelf Allogeneic Stem Cell Product for the Treatment of... - October 29th, 2020
- Why Small Businesses Matter in Wilton (Reimagined): Interventional Orthopedics Connecticut - HamletHub - October 29th, 2020
- Covid-19 Impact On Orthopedic Regenerative Medicine Market 2020 Future Development, Manufacturers, Trends, Share, Size And Forecast to 2027 |... - October 29th, 2020
- Cell Expansion Market a comprehensive study by key players- Thermo Fisher Scientific, Inc, Becton, Dickinson and Company, Terumo BCT, Merck KGaA and... - October 24th, 2020
- Genmab Announces IFM, HOVON and Janssen Achieve Positive Topline Results in Second Part of Phase 3 CASSIOPEIA Study of Daratumumab in Multiple Myeloma... - October 24th, 2020
- What Is the Role of Allogeneic-SCT in Adult Acute Lymphoblastic Leukemia in the Era of Targeted Therapies? - Targeted Oncology - October 21st, 2020
- Cell Therapy Market Size, Share, Market Research and Industry Forecast Report, 2020-2027 (Includes Business Impact of COVID-19) - Eurowire - October 17th, 2020
- Global Stem Cell Therapy Market (Covid-19 updated report), Trends, Top Manufacturers, Exponential Growth and Forecast 2020 to 2027 By Reportspedia -... - October 17th, 2020
- Was Trump's Regeneron 'Cure' Developed Using Stem Cells and Fetal Tissues? - Snopes.com - October 13th, 2020
- The complicated story of Trump's COVID treatment, stem cells and abortion politics - Baptist News Global - October 13th, 2020
- BrainStorm to Present at the 2020 Cell & Gene Meeting on the Mesa - PRNewswire - October 13th, 2020
- Human heart organoids provide unmatched insight into cardiac disease and dysfunction - BioWorld Online - October 13th, 2020
- Sickle Cell Disease Association of America and Aruvant Sciences Forge New Partnership to Educate Around Gene Therapy - Herald-Mail Media - October 13th, 2020
- Q Stock; The Rise of BioRestorative Therapies Inc (OTCMKTS: BRTXQ) - MicroCap Daily - October 8th, 2020
- A Uniquely Patient-Focused Take on Treating AML in Older Adults - Medscape - October 8th, 2020
- Dust off the crystal ball: It's time for STAT's 2020 Nobel Prize predictions - STAT - October 3rd, 2020
- BrainStorm Cell Therapeutics to Announce Third Quarter Financial Results and Provide a Corporate Upd - PharmiWeb.com - October 3rd, 2020
- Cell Harvesting Market to Witness Steady Expansion During 2018-2023 - The Market Records - October 1st, 2020
- Global Mesenchymal Stem Cells Market to Witness Exponential Rise in Revenue Share During the Forecast Period - Lake Shore Gazette - September 7th, 2020
- Keeping kids and adults alike healthy with Colostrum - North Coast Courier - September 4th, 2020
- Newly discovered molecule could play key role in treating osteoarthritis - Irish Examiner - September 4th, 2020
- Stem Cell Therapy Market (Covid 19 Impact) Research Outlook, Recent Trends and Growth Forecast 2020-2025 - TC BizNews - September 4th, 2020
- Shielded Stem Cells Improve The Cells' Ability To Heal Heart Injuries - Interesting Engineering - August 21st, 2020
- Steadman Philippon Research Institute (SPRI) Receives Multi-Million-Dollar Matching Grant from the National Institutes of Health - GlobeNewswire - August 21st, 2020
- Worldwide Dilated Cardiomyopathy (DCM) Market Insights, Epidemiology and Forecast - 2030 - ResearchAndMarkets.com - Business Wire - August 21st, 2020